Talk:MEK inhibitor

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Sensitises cancers to immunotherapy[edit]

Anti–PD-L1 Immunotherapy, MEK Inhibition Active in Metastatic CRC says "... previous studies have suggested that MEK inhibition could make a tumor more responsive to immunotherapy." - Could find some RS to add this. - Rod57 (talk) 20:02, 5 July 2016 (UTC)[reply]